1 – 10 of 14
      - show: 10
 - |
 - sort: year (new to old)
 
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
 - 
                        Mark
        When is ABO-incompatible plasma safe to transfuse? : Defining an empirical estimation of anti-A/anti-B in ABO incompatible plasma-containing blood products
    
    
- Contribution to journal › Scientific review
 
 - 2022
 - 
                        Mark
        International Forum on Policies and Practice for Transfusion of ABO and RhD Non-Identical Platelets : Responses
    
    
- Contribution to journal › Scientific review
 
 - 
                        Mark
        ABO and RhD blood group are not associated with mortality and morbidity in critically ill patients; a multicentre observational study of 29 512 patients
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        International Forum on Policies and Practice for Transfusion of ABO and RhD Non-Identical Platelets : Summary
    
    
- Contribution to journal › Article
 
 - 2021
 - 
                        Mark
        Novel single nucleotide deletion in ART4 accounts for the Gy(a-) phenotype in a woman of Lebanese origin
    
    
- Contribution to journal › Article
 
 - 2019
 - 
                        Mark
        Automatic for the people : a rapidly evolving movement for the future of genotyping
    
    
- Contribution to journal › Debate/Note/Editorial
 
 - 2018
 - 
                        Mark
        Bioinformatic studies of genetic variation at known, novel and candidate blood group loci
    
    
- Thesis › Doctoral thesis (compilation)
 
 - 
                        Mark
        Identification of human glycosyltransferase genes expressed in erythroid cells predicts potential carbohydrate blood group loci
    
    
- Contribution to journal › Article
 
 - 2017
 - 
                        Mark
        Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP53 mutations
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        SMIM1 variants rs1175550 and rs143702418 independently modulate Vel blood group antigen expression
    
    
- Contribution to journal › Article
 
 
